TY - JOUR
T1 - COVID-19 in Chronic Liver Disease and Liver Transplantation
T2 - A Clinical Review
AU - Mohammed, Abdul
AU - Paranji, Neethi
AU - Chen, Po Hung
AU - Niu, Bolin
N1 - Publisher Copyright:
© Copyright 2020 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelationship with COVID-19 infection in cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, autoimmune hepatitis, and viral hepatitis B. As social distancing and telemedicine gain new footing, we synthesize recommendations from 3 major hepatology societies [American Association for the Study of Liver Disease (AASLD), the European Association for the Study of Liver (EASL), and the Asian Pacific Association for the Study of Liver (APASL)] to present the best approaches for caring for patients with liver diseases as well as those requiring liver transplantation.
AB - The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelationship with COVID-19 infection in cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, autoimmune hepatitis, and viral hepatitis B. As social distancing and telemedicine gain new footing, we synthesize recommendations from 3 major hepatology societies [American Association for the Study of Liver Disease (AASLD), the European Association for the Study of Liver (EASL), and the Asian Pacific Association for the Study of Liver (APASL)] to present the best approaches for caring for patients with liver diseases as well as those requiring liver transplantation.
KW - COVID-19
KW - SARS-CoV-2
KW - autoimmune hepatitis
KW - cirrhosis
KW - hepatitis B
KW - hepatocellular carcinoma
KW - liver transplantation
KW - nonalcoholic liver disease
KW - review
UR - http://www.scopus.com/inward/record.url?scp=85099155974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099155974&partnerID=8YFLogxK
U2 - 10.1097/MCG.0000000000001481
DO - 10.1097/MCG.0000000000001481
M3 - Review article
C2 - 33394628
AN - SCOPUS:85099155974
VL - 55
SP - 187
EP - 194
JO - Journal of Clinical Gastroenterology
JF - Journal of Clinical Gastroenterology
SN - 0192-0790
IS - 3
ER -